These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. When a heel wound is not just a wound: an unusual presentation of malignant melanoma. Petronzio A; Smith M; Drake M; Cowardbéy K Int J Dermatol; 2023 Oct; 62(10):e566-e567. PubMed ID: 37264695 [No Abstract] [Full Text] [Related]
3. Myositis and metastatic melanoma. Karsan N; Barker R; Wren D Clin Med (Lond); 2015 Apr; 15(2):210. PubMed ID: 25824080 [No Abstract] [Full Text] [Related]
4. Primary Regressive, But Metastasizing Melanoma!? Tchernev G; Temelkova I Open Access Maced J Med Sci; 2019 Mar; 7(5):893-895. PubMed ID: 30962857 [TBL] [Abstract][Full Text] [Related]
5. Segmental vitiligo-like hypopigmentation associated with metastatic melanoma. Cerci FB; Mesquita LA; Silva de Castro CC Cutis; 2017 Jun; 99(6):E1-E2. PubMed ID: 28686764 [No Abstract] [Full Text] [Related]
6. Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field. Lommerts JE; Teulings HE; Ezzedine K; van Geel N; Hartmann A; Speeckaert R; Spuls PI; Wolkerstorfer A; Luiten RM; Bekkenk MW J Am Acad Dermatol; 2016 Dec; 75(6):1198-1204. PubMed ID: 27717621 [TBL] [Abstract][Full Text] [Related]
7. [Vitiliginous depigmentation in patients suffering from malignant melanoma]. Frenk E Dermatologica; 1969; 139(1):84-91. PubMed ID: 5810156 [No Abstract] [Full Text] [Related]
8. Hypopigmentation, vitiligo, and melanoma. New data, more enigmas. Nordlund JJ Arch Dermatol; 1987 Aug; 123(8):1005-8. PubMed ID: 3631979 [No Abstract] [Full Text] [Related]